47 related articles for article (PubMed ID: 18753829)
1.
Santos-Cuevas C; Ferro-Flores G; García-Pérez FO; Jiménez-Mancilla N; Ramírez-Nava G; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Davanzo J; Soldevilla-Gallardo I
Contrast Media Mol Imaging; 2018; 2018():5247153. PubMed ID: 30534027
[TBL] [Abstract][Full Text] [Related]
2. Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nanoparticles.
Pérez-Velasco DL; Morales-Avila E; Ocampo-García B; Torres-García E; Izquierdo G; Jiménez-Mancilla N; Oros-Pantoja R; Díaz-Sánchez LE; Aranda-Lara L; Isaac-Olivé K
Nucl Med Biol; 2023; 122-123():108363. PubMed ID: 37419070
[TBL] [Abstract][Full Text] [Related]
3.
Lambert B; Carron P; D'Asseler Y; Bacher K; Van den Bosch F; Elewaut D; Verbruggen G; Beyaert R; Dumolyn C; De Vos F
EJNMMI Res; 2016 Dec; 6(1):88. PubMed ID: 27957720
[TBL] [Abstract][Full Text] [Related]
4. Targeting prostate cancer with radiolabelled bombesins.
Maina T; Nock B; Mather S
Cancer Imaging; 2006 Nov; 6(1):153-7. PubMed ID: 17098646
[TBL] [Abstract][Full Text] [Related]
5. Gastrin-releasing peptide receptor as a theranostic target in breast cancer: a systematic scoping review.
Baun C; Naghavi-Behzad M; Hildebrandt MG; Gerke O; Thisgaard H
Semin Nucl Med; 2024 Mar; 54(2):256-269. PubMed ID: 38342656
[TBL] [Abstract][Full Text] [Related]
6. Intravial or In Vivo Production of 99mTc-Dextrose Complexes May Play a Role in Altering Biodistribution of 99mTc-HYNIC-Octreotide Scan.
Qutbi M; Shafiei B; Asli IN
Clin Nucl Med; 2021 Oct; 46(10):859-860. PubMed ID: 34477603
[No Abstract] [Full Text] [Related]
7. Imaging Properties and Tumor Targeting of
Gruber L; Decristoforo C; Uprimny C; Hohenberger P; Schoenberg SO; Orlandi F; Mariani MF; Manzl C; Kasseroler MT; Tilg H; Zelger B; Jaschke WR; Virgolini IJ
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428467
[TBL] [Abstract][Full Text] [Related]
8. Theranostic Advances in Breast Cancer in Nuclear Medicine.
Vahidfar N; Aghanejad A; Ahmadzadehfar H; Farzanehfar S; Eppard E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925632
[TBL] [Abstract][Full Text] [Related]
9. Hybrid (2D/3D) Dosimetry of Radiolabeled Gold Nanoparticles for Sentinel Lymph Node Detection in Patients with Breast Cancer.
Ramírez-Nava G; Santos-Cuevas C; Ferro-Flores G; Ocampo-García B; Chairez I; Gómez-Argumosa E; Abundiz-López L; García-Pérez FO
Contrast Media Mol Imaging; 2020; 2020():2728134. PubMed ID: 32489332
[TBL] [Abstract][Full Text] [Related]
10. Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells.
Akbar MJ; Lukasewicz Ferreira PC; Giorgetti M; Stokes L; Morris CJ
Beilstein J Nanotechnol; 2019; 10():2553-2562. PubMed ID: 31921534
[No Abstract] [Full Text] [Related]
11. First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist
Gnesin S; Cicone F; Mitsakis P; Van der Gucht A; Baechler S; Miralbell R; Garibotto V; Zilli T; Prior JO
EJNMMI Res; 2018 Dec; 8(1):108. PubMed ID: 30543050
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Biokinetic Modelling of Tc-99m Radiophamaceuticals Obtained from Semi-Automatic Image Processing.
Cornejo-Aragón LG; Santos-Cuevas CL; Ocampo-García BE; Chairez-Oria I; Diaz-Nieto L; García-Quiroz J
J Med Biol Eng; 2017; 37(6):887-898. PubMed ID: 29541015
[TBL] [Abstract][Full Text] [Related]
13. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.
Moreno P; Ramos-Álvarez I; Moody TW; Jensen RT
Expert Opin Ther Targets; 2016 Sep; 20(9):1055-73. PubMed ID: 26981612
[TBL] [Abstract][Full Text] [Related]
14. Bombesin receptor-mediated imaging and cytotoxicity: review and current status.
Sancho V; Di Florio A; Moody TW; Jensen RT
Curr Drug Deliv; 2011 Jan; 8(1):79-134. PubMed ID: 21034419
[TBL] [Abstract][Full Text] [Related]
15. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer.
Liu Z; Yan Y; Liu S; Wang F; Chen X
Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537
[TBL] [Abstract][Full Text] [Related]
16. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
[TBL] [Abstract][Full Text] [Related]
17. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
18. Biokinetics and dosimetry in patients of 99mTc-EDDA/HYNIC-Tyr3-octreotide prepared from lyophilized kits.
González-Vázquez A; Ferro-Flores G; Arteaga de Murphy C; Gutiérrez-García Z
Appl Radiat Isot; 2006 Jul; 64(7):792-7. PubMed ID: 16542847
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT
Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
